A precursor B cell undergoes an abnormal mitosis that results in hyperdiploidy. A selective advantage is conferred, resulting in a preleukemic clone, and second “hits” result in the fully malignant phenotype. Hyperdiploid cells display unusual sensitivity to chemotherapy through as-yet-undefined mechanisms.